Rubicon Research Ltd
NSE: RUBICON BSE: 544578
₹967.90
(1.01%)
Wed, 27 May 2026, 06:43 pm
Market Cap161.36B
PE Ratio0
Dividend0
Health Technology
Biotechnology
24.5KRubicon Research Cashflow
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Deprecation and amortization | -340.07M | -360.61M | -389.73M | -365.90M |
| Accumulated depreciation, total | -726.79M | -914.09M | -1.12B | -1.28B |
| Cash from operating activities | -701.17M | -910.35M | -71.49M | 1.28B |
| Funds from operations | -545.42M | 170.74M | 1.28B | 2.18B |
| Net income (cash flow) | -671.18M | -168.88M | 910.12M | 1.34B |
| Depreciation & amortization (cash flow) | 340.07M | 360.61M | 389.73M | 365.90M |
| Depreciation/depletion | 191.16M | 219.47M | 262.59M | 306.27M |
| Amortization | 148.91M | 141.14M | 127.14M | 59.63M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 |
| Non-cash items | -224.37M | -79.38M | -138.95M | -133.81M |
| Changes in working capital | -155.75M | -1.08B | -1.35B | -900.04M |
| Cash from investing activities | -567.86M | -349.56M | -701.53M | -661.41M |
| Capital expenditures | -545.01M | -444.64M | -561.43M | -702.24M |
| Capital expenditures - fixed assets | -545.01M | -444.64M | -561.43M | -702.24M |
| Capital expenditures - other assets | — | — | — | — |
| Cash from financing activities | 724.00M | 1.40B | 733.51M | -70.29M |
| Free cash flow | -1.25B | -1.35B | -632.92M | 575.05M |